{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:48:32Z","timestamp":1785930512288,"version":"3.56.0"},"reference-count":92,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:p>Triethylene Glycol and PEG-4 (polyethylene glycol) are polymers of ethylene oxide alcohol. Triethylene Glycol is a specific three-unit chain, whereas PEG-4 is a polymer with an average of four units, but may contain polymers ranging from two to eight ethylene oxide units. In the same manner, other PEG compounds, e.g., PEG-6, are mixtures and likely contain some Triethylene Glycol and PEG-4. Triethylene Glycol is a fragrance ingredient and viscosity decreasing agent in cosmetic formulations, with a maximum concentration of use of 0.08% in skin-cleansing products. Following oral doses, Triethylene Glycol and its metabolites are excreted primarily in urine, with small amounts released in feces and expired air. With oral LD50 values in rodents from 15 to 22 g\/kg, this compound has little acute toxicity. Rats given short term oral doses of 3% in water showed no signs of toxicity, whereas all rats given 10% died by the 12th day of exposure. At levels up to 1 g\/m3, rats exposed to aerosolized Triethylene Glycol for 6 h per day for 9 days showed no signs of toxicity. Rats fed a diet containing 4% Triethylene Glycol for 2 years showed no signs of toxicity. There were no treatment-related effects on rats exposed to supersaturated Triethylene Glycol vapor for 13 months nor in rats that consumed 0.533 cc Triethylene Glycol per day in drinking water for 13 months. Triethylene Glycol was not irritating to the skin of rabbits and produced only minimal injury to the eye. In reproductive and developmental toxicity studies in rats and mice, Triethylene Glycol did not produce biologically significant embryotoxicity or teratogenicity. However, some maternal toxicity was seen in dams given 10 ml\/kg\/day during gestation. Triethylene Glycol was not muta-genic or genotoxic in Ames-type assays, the Chinese hamster ovary mutation assay, and the sister chromatid exchange assays. PEG-4 is a humectant and solvent in cosmetic products, with a maximum concentration of use of 20% in the \u201cother manicuring preparations\u201d product category. This ingredient, with an oral LD50 in rats of 32.77 g\/kg, has low acute toxicity. Rats given up to 50,000 ppm PEG-4 in drinking water for 5 days showed no permanent signs of toxicity. Rats given daily oral doses up to 2 g\/kg\/day of PEG-4 for 33 days showed no signs of toxicity. Undiluted PEG-4 produced only minimal injury to the rabbit eye. PEG-4 was not mutagenic in Ames-type assays, did not induce chromosome aberration in an in vivo bone marrow assay, and was negative for genotoxicity in a dominant lethal assay using rats. Other PEG compounds, which have previously been reviewed by the Cosmetic Ingredient Review (CIR) Expert Panel, e.g., PEG-6, are mixtures that likely include Triethylene Glycol and PEG-4, so these data were also considered. PEG-6 and PEG-8 were not dermal irritants in several rabbit studies. PEG-2 Stearate had a potential for slight irritation in rabbits but was not a sensitizer in guinea pigs. PEG-2 Cocamine was a moderate irritant in rabbits, producing severe erythema. In one dermal study, PEG-2 Cocamine was determined to be corrosive to rabbit skin, causing eschar and necrosis. PEG-6 and PEG-8 caused little to no ocular irritation. PEG-8 was not mutagenic or genotoxic in a Chinese hamster ovary assay, a sister-chromatid exchange assay, and in an unscheduled DNA synthesis assay. In clinical studies on normal skin, PEG-6 and PEG-8 caused mild cases of immediate hypersensitivity; PEG-8 was not a sensitizer; PEG-2 Stearate was not an irritant, a sensitizer, or a photosensitizer; and PEG-6 Stearate was not an irritant or sensitizer. In damaged skin, cases of systemic toxicity and contact dermatitis in burn patients were attributed toa PEG-based topical ointment. The CIR Expert Panel acknowledged the lack of dermal sensitization data for Triethylene Glycol and dermal irritation and sensitization data for PEG-4. That PEG-6, PEG-8, and PEG-2 Stearate were not irritants or sensitizers suggested that Triethylene Glycol and PEG-4 also would not be irritants or sensitizers, and the absence of any reported reactions in the case literature and the professional experience of the Expert Panel further supported the absence of any significant sensitization potential. The need for additional data to demonstrate the safety of PEGs Cocamine was related to the Cocamine moiety and is not relevant here. The Panel reminded formulators of cosmetic products that, as with other PEG compounds, Triethylene Glycol and PEG-4 should not be used on damaged skin because of cases of systemic toxicity and contact dermatitis in burn patients have been attributed to a PEG-based topical ointment. Based on its consideration of the available information, the CIR Expert Panel concluded that Tri-ethylene Glycol and PEG-4 are safe as cosmetic ingredients in the present practices and concentrations of use as described in this safety assessment.<\/jats:p>","DOI":"10.1080\/10915810600964642","type":"journal-article","created":{"date-parts":[[2006,11,7]],"date-time":"2006-11-07T14:56:18Z","timestamp":1162911378000},"page":"121-138","source":"Crossref","is-referenced-by-count":10,"title":["Final Report on the Safety Assessment of Triethylene Glycol and PEG-41"],"prefix":"10.1177","volume":"25","member":"179","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.3109\/10915819309141598"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1080\/109158199225639"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1080\/109158199225620"},{"issue":"2","key":"atypb4","first-page":"53","volume":"18","year":"1999","journal-title":"Intl. J. Toxicol."},{"key":"atypb5","first-page":"29","volume":"19","year":"2000","journal-title":"J. Am. Coll. Toxicol."},{"key":"atypb6","unstructured":"Armak. 1972. PEG Stearate skin irritation data. Unpublished data submitted by CTFA."},{"key":"atypb7","volume-title":"Ashford's dictionary of industrial chemicals.","year":"1994"},{"key":"atypb8","first-page":"501","volume":"15","year":"1955","journal-title":"Cancer Res."},{"key":"atypb9","first-page":"26","volume":"39","year":"1997","journal-title":"Vet. Human Toxicol."},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(92)90120-7"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(68)90022-4"},{"key":"atypb12","first-page":"385","volume":"44","year":"1969","journal-title":"Z. Hauktr."},{"key":"atypb13","volume-title":"The Merck Index: An encyclopedia of chemicals, drugs, and biologicals","year":"1989"},{"key":"atypb14","unstructured":"Bushy Run Research Center. 1980. Submission of unpublished data by CTFA. Polyethylene glycol-400 Carbowax.\n                      In vitro\n                      mutagenesis studies. 3-test battery (15 pages.)"},{"key":"atypb15","unstructured":"Caltex Australia Petroleum Pty, Ltd. (1997). Material safety data sheet: Brake fluid. Unpublished data submitted by American Chemistry Council (4 pages.)"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030410112"},{"key":"atypb17","first-page":"1363","volume":"28","year":"1946","journal-title":"Am. J. Opthalmol."},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1969.53"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32196-1"},{"key":"atypb20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0021-9258(18)84780-9","volume":"66","year":"1925","journal-title":"J. Biol. Chem."},{"key":"atypb21","unstructured":"Cosmetic, Toiletries and Fragrance Association (CTFA). 1978a. Acute oral toxi-city, eye irritation, skin irritation of Varonic (PEG-2 Cocamine). Unpublished data submitted by CTFA (5 pages.)"},{"key":"atypb22","unstructured":"CTFA. 1978d. FHSA primary skin irritation study of Varonic K202 (PEG-2 Cocamine) in rabbits. Unpublished data submitted by CTFA (9 pages.)"},{"key":"atypb23","unstructured":"CTFA 1978b. Skin irritation study of the test material Varonic K215 (PEG-15 Cocamine) in rabbits. Unpublished data submitted by CTFA (9 pages.)"},{"key":"atypb24","unstructured":"CTFA. 1979. Additional cosmetic products containing PEG stearate. Unpublished data submitted by CTFA (1 page.)"},{"key":"atypb25","unstructured":"CTFA. 1980. Allergic contact sensitization test. 14A\/16427-14 containing 3.0% PEG-8 (RI 0639). Unpublished data submission by CTFA (11 pages.)"},{"key":"atypb26","unstructured":"CTFA. 1982a. Submission of unpublished safety data. Allergic contact sensiti-zation test. 12A\/23379-04 containing 1.0% PEG-8 (RI 0639). Unpublished data submission by CTFA (8 pages.)"},{"key":"atypb27","unstructured":"CTFA. 1982b. Allergic contact sensitization test. 12J\/22879-07 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (8 pages.)"},{"key":"atypb28","unstructured":"CTFA. 1982c. Allergic contact sensitization test. 12J\/12829-19 containing 1.0% 2"},{"key":"atypb29","unstructured":"CTFA. 1982d. Allergic contact sensitization test. 12J\/25402-16 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (7 pages.)"},{"key":"atypb30","unstructured":"CTFA. 1983a. Allergic contact sensitization test. 12C\/25613-05 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (7 pages.)"},{"key":"atypb31","unstructured":"CTFA. 1983b. Allergic contact sensitization test. 12F\/27764-06 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA.(8 pages.)"},{"key":"atypb32","unstructured":"CTFA. 1984. Allergic contact sensitization test. 12F\/30612-03 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (9 pages.)"},{"key":"atypb33","unstructured":"CTFA. 1985. Allergic contact sensitization test. 12G\/34562-12 containing 1.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (10 pages.)"},{"key":"atypb34","unstructured":"CTFA. 2002. Current concentration of use data for Triethylene Glycol and PEG-4. Unpublished data submitted by CTFA, April 26, 2002 (1 page.)"},{"key":"atypb35","doi-asserted-by":"crossref","unstructured":"Elder, R. L. 1983. Final report on the safety assessment of polyethylene glycols (PEGs)-2,6,8,12,20,32,40,50,100, and-150 stearates.\n                      J. Am. Coll. Toxicol.\n                      2:17-34.","DOI":"10.3109\/10915818309142000"},{"key":"atypb36","unstructured":"European Commission. 2002. The rules governing cosmetic products in the European Union. Volume 1. Cosmetics legislation-Cosmetic products. http:\/\/dg3.eudra.org\/F3\/home.html. Accessed January 9, 2002."},{"key":"atypb37","first-page":"409","volume":"19","year":"1977","journal-title":"Cutis."},{"key":"atypb38","first-page":"135","volume":"43","year":"1978","journal-title":"Contact Dermatitis"},{"key":"atypb39","first-page":"40","volume":"28","year":"1946","journal-title":"J. Ind. Hyg. Toxicol."},{"key":"atypb40","unstructured":"Food and Drug Administration (FDA). 1984. Frequency of use of cosmetic ingredients.\n                      FDA database.\n                      Washington, DC: FDA."},{"key":"atypb41","unstructured":"FDA. 2001. Frequency of use of cosmetic ingredients.\n                      FDA database.\n                      Washington, DC: FDA."},{"key":"atypb42","unstructured":"Food and Drug Research Labs.1982. Safety test data on PEG-2 Stearate and PEG-8 Stearate. Unpublished data submitted by CTFA."},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1982.tb00301.x"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1975.tb05336.x"},{"key":"atypb45","unstructured":"Hazleton Laboratories America, Inc. 1985. D. O. T. Skin corrosivity-method, summary, raw data appendix for Varonic K202 (PEG-2 Cocamine). Unpublished data submitted by CTFA (5 pages.)"},{"key":"atypb46","unstructured":"Hill Top Research, Inc. 1979. The study of cummulative irritant properties of a series test materials. 14A\/16427-09 containing 3.0% PEG-8 (RI 0639). Unpublished data submitted by CTFA (14 pages.)"},{"key":"atypb47","unstructured":"Inolex. 1975. PEG-2 safety test data. Unpublished data submitted by CTFA."},{"key":"atypb48","first-page":"338","volume":"90","year":"1947","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"atypb49","doi-asserted-by":"publisher","DOI":"10.1128\/aem.35.4.679-684.1978"},{"key":"atypb50","volume-title":"Kirk-Othmer concise encyclopedia of chemical technology","year":"1999"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)91686-7"},{"key":"atypb52","first-page":"336","volume":"17","year":"1976","journal-title":"Proc. Eur. Soc. Toxicol."},{"key":"atypb53","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.105-1470218"},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030290103"},{"key":"atypb55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1975.tb05400.x"},{"key":"atypb56","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(62)90029-7"},{"key":"atypb57","unstructured":"Ministry of Health, Labor and Welfare. 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumgaseki, Chiyoda-ku, Tokyo 100-8045, Japan."},{"key":"atypb58","unstructured":"Ministry of Health, Labor and Welfare. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health, Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2, 1-chome, Kasumgaseki, Chiyoda-ku, Tokyo 100-8045, Japan."},{"issue":"7","key":"atypb59","first-page":"1","volume":"8","year":"1986","journal-title":"Environ. Mutagen."},{"key":"atypb60","unstructured":"National Toxicology Program (NTP). 2001a. Health and safety data: Polyethylene glycol 200. Research Triangle Park:NTP. http:\/\/ntp-server.niehs.nih.gov\/htdocs\/CHEM H&S\/NTP Chem2\/Radian25322-68-3. html. Downloaded November 5, 2001."},{"key":"atypb61","unstructured":"National Toxicology Program (NTP). 2001b. Health and safety data: Triethylene glycol. Research Triangle Park:NTP. http:\/\/ntp-server.niehs.nih.gov\/htdocs\/CHEM H&S\/NTP Chem1\/Radian112-27-6.html. Downloaded November 5, 2001."},{"key":"atypb62","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0015-6264(79)80096-6","volume":"17","year":"1979","journal-title":"Food Chem. Toxicol."},{"key":"atypb63","volume-title":"International cosmetic ingredient dictionary and handbook","year":"2002"},{"key":"atypb64","first-page":"52","volume":"91","year":"1947","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"atypb65","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-6264(66)80569-2"},{"key":"atypb66","unstructured":"Schick, M. J.1966.Nonionic surfactants, 800. New York: Marcel Dekker."},{"key":"atypb67","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-2993(98)80096-1"},{"key":"atypb68","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030390613"},{"key":"atypb69","unstructured":"Sigma-Aldrich. 2001a. Certificate of analysis, tri(ethylene glycol), 99%. On the Sigma-Aldrich website. http:\/\/www.sigma-aldrich.com."},{"key":"atypb70","unstructured":"Sigma-Aldrich. 2001b. Certificate of analysis, tetra(ethylene glycol), 99%. On the Sigma-Aldrich website. http:\/\/www.sigma-aldrich.com."},{"key":"atypb71","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(83)90365-0"},{"key":"atypb72","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030340606"},{"key":"atypb73","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030390615"},{"key":"atypb74","first-page":"259","volume":"23","year":"1941","journal-title":"J. Ind. Hyg. Toxicol."},{"key":"atypb75","unstructured":"Union Carbide. 1986a. Triethylene glycol: in vitro genotoxicity studies: CHO\/HGPRT mutation test sister chromatid exchange assay. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb76","unstructured":"Union Carbide. 19986b. Triethylene glycol: In vitro chromosome aberration study. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb77","unstructured":"Union Carbide. 1986c. Triethylene glycol: In vitro genotoxicity studies: CHO\/HGPRT mutation test sister chromatid exchange assay. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb78","unstructured":"Union Carbide. 1986d. Triethylene glycol: In vitro chromosome aberration study. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb79","unstructured":"Union Carbide. 1988. Tetraethylene glycol in vivo clastogenic potential using the bone marrow aberration assay in rats with cover letter dated 101788. NTIS Report No. OTS0513409-1."},{"key":"atypb80","unstructured":"Union Carbide. 1989a. Triethylene glycol: Fourteen-day dietary toxicity study in Fischer 344 rats. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb81","unstructured":"Union Carbide, 1989b. Letter from Union Carbide Corporation to the USEPA concerning information on tetraethylene glycol. NTIS Report No. OTS0513409-2."},{"key":"atypb82","unstructured":"Union Carbide. 1990a. Material safety data sheet: Triethylene glycol. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb83","unstructured":"Union Carbide. 1990b. Triethylene glycol (TEG): Acute aerosol inhalation tox-icity test in rats. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb84","unstructured":"Union Carbide. 1990c. Triethylene glycol: Ninety-day dietary toxicity study in Fischer 344 rats. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb85","unstructured":"Union Carbide. 1990d. Triethylene glycol: Acute toxicity and primary irritancy studies. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb86","unstructured":"Union Carbide. 1990e. Developmental toxicity study of triethylene glycol administered by gavage to CD-1 mice. Included in NTIS Report No. OTS0527779-1."},{"key":"atypb87","unstructured":"Union Carbide. 1991. Developmental toxicity study of triethylene glycol administered by gavage to CD (Sprague-Dawley) rats. NTIS Report No. OTS0527779-4."},{"key":"atypb88","unstructured":"Union Carbide. 1992. Nine-day aerosol study of triethylene glycol in rats with cover letter dated 010693. NTIS Report No. OTS0537563-1."},{"key":"atypb89","unstructured":"Union Carbide. 1993. Letter from Union Carbide Corp to USEPA regarding sensory irritation study and developmental toxicity evaluation of triethy-lene glycol with attachments dated 101593. Included in NTIS Report No. OTS0537563-1."},{"key":"atypb90","unstructured":"Union Carbide. 1994. Support: Dominant lethal assay of tetraethylene glycol in ischer 344 rats with cover letter dated 010494. NTIS Report No. OTS0513409-5"},{"key":"atypb91","first-page":"773","volume":"37","journal-title":"Clin. Toxicol."},{"key":"atypb92","doi-asserted-by":"publisher","DOI":"10.1007\/BF00600756"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810600964642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810600964642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:22:22Z","timestamp":1777458142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/10915810600964642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":92,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1080\/10915810600964642"],"URL":"https:\/\/doi.org\/10.1080\/10915810600964642","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}